Risk Factors for Blood Clots While Taking GLP-1 Agonists While GLP-1 receptor agonists do not directly cause blood clots, patients taking these medications may have multiple independent risk factors for thromboembolism that warrant clinical attention
A 2023 Nature report at the beginning of the year, extolling breakthrough obesity drugs, focused just on Habener and Drucker
Aqneursa was well-tolerated, with common side effects being vomiting, abdominal pain, difficulty swallowing and upper respiratory tract infections
"When levels of GLP-1 drop, the effects of the medication will start to wear off
J Clin Invest 110(8):10931103 Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H et al (1996) The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
Bacillus subtilis , Clostridium perfringens , and Lactobacillus casei (phylum Bacillota)